Pmanek Biofarms Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 21 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2021)
- Profit 76.06%
(FY 2021)
- Ebitda -3200.03%
(FY 2021)
- Net Worth -43.32%
(FY 2021)
- Total Assets -98.18%
(FY 2021)
About Pmanek Biofarms
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nilesh Manek, Rupalbaa Manek, and Parmaben Manek serve as directors at the Company.
- CIN/LLPIN
U24233GJ2003PTC042852
- Company No.
042852
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Sep 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Jamnagar, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pmanek Biofarms?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Manek  | Director | 03-Sep-2003 | Current |
| Rupalbaa Manek | Director | 10-Nov-2019 | Current |
| Parmaben Manek | Director | 10-Nov-2019 | Current |
Financial Performance of Pmanek Biofarms.
Pmanek Biofarms Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 76.06% increase in profit. The company's net worth observed a substantial decline by a decrease of 43.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pmanek Biofarms?
In 2021, Pmanek Biofarms had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Inland Mines And Minerals Private LimitedActive 19 years 7 monthsNilesh Manek and Parmaben Manek are mutual person
- Viram Asha Shipping Services LimitedActive 28 years 2 months
Nilesh Manek, Rupalbaa Manek and 1 more are mutual person
- Shivani Clearing And Forwading LimitedActive 22 years 4 months
Nilesh Manek and Parmaben Manek are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pmanek Biofarms?
Unlock and access historical data on people associated with Pmanek Biofarms, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pmanek Biofarms, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pmanek Biofarms's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
